Search

Your search keyword '"van Roosmalen, Markus J."' showing total 61 results

Search Constraints

Start Over You searched for: Author "van Roosmalen, Markus J." Remove constraint Author: "van Roosmalen, Markus J." Database OAIster Remove constraint Database: OAIster
61 results on '"van Roosmalen, Markus J."'

Search Results

1. Transient Differentiation-State Plasticity Occurs during Acute Lymphoblastic Leukemia Initiation

2. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms

3. Mitochondrial H2O2 release does not directly cause damage to chromosomal DNA.

4. Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis Toolbox

5. Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis Toolbox

6. A multi-platform reference for somatic structural variation detection

7. Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to TherapyRelated Myeloid Neoplasms

8. Article Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo

9. MutationalPatterns: the one stop shop for the analysis of mutational processes

10. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns

11. Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients

12. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns

13. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients

14. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns

15. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants

16. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

17. Identification of human D lactate dehydrogenase deficiency

18. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants

19. Identification of human D lactate dehydrogenase deficiency

20. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

21. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

22. Identification of human D lactate dehydrogenase deficiency

23. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants

24. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

25. Identification of human D lactate dehydrogenase deficiency

26. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants

27. Identification of human D lactate dehydrogenase deficiency

28. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

29. Identification of human D lactate dehydrogenase deficiency

30. Mapping and phasing of structural variation in patient genomes using nanopore sequencing

31. Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells

32. Mapping and phasing of structural variation in patient genomes using nanopore sequencing

33. Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells

34. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

35. Mapping and phasing of structural variation in patient genomes using nanopore sequencing

36. Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells

37. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

38. Mapping and phasing of structural variation in patient genomes using nanopore sequencing

39. Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells

40. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

41. Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease

42. Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease

43. Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease

44. Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease

45. Characteristics of de novo structural changes in the human genome

46. Chromothripsis in Healthy Individuals Affects Multiple Protein-Coding Genes and Can Result in Severe Congenital Abnormalities in Offspring

47. Characteristics of de novo structural changes in the human genome

48. Chromothripsis in Healthy Individuals Affects Multiple Protein-Coding Genes and Can Result in Severe Congenital Abnormalities in Offspring

49. Chromothripsis in healthy individuals affects multiple protein-coding genes and can result in severe congenital abnormalities in offspring

50. Characteristics of de novo structural changes in the human genome

Catalog

Books, media, physical & digital resources